Holen Sie sich die Stockscreener-App
1.52
1.33%
0.02
Handel nachbörslich:
1.53
0.01
+0.66%
Schlusskurs vom Vortag:
$1.50
Offen:
$1.51
24-Stunden-Volumen:
66,793
Relative Volume:
0.29
Marktkapitalisierung:
$116.17M
Einnahmen:
$4.29M
Nettoeinkommen (Verlust:
$-104.03M
KGV:
-0.7722
EPS:
-1.9685
Netto-Cashflow:
$-50.65M
1W Leistung:
-5.59%
1M Leistung:
-9.52%
6M Leistung:
-47.04%
1J Leistung:
+16.92%
1-Tages-Spanne:
$1.48
$1.5394
1-Wochen-Bereich:
$1.48
$1.675
52-Wochen-Spanne:
$1.09
$4.1907
Cibus Inc Stock (CBUS) Company Profile
Firmenname
Cibus Inc
Sektor
Branche
Telefon
(858) 450-0008
Adresse
6455 NANCY RIDGE DRIVE, SAN DIEGO
Compare CBUS vs VRTX, REGN, MRNA, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
1.52 | 114.64M | 4.29M | -104.03M | -50.65M | -1.9685 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 132.40B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.95B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 77.78B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.20B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 42.84B | 742.00K | -1.37B | -1.07B | -7.0731 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-29 | Eingeleitet | Alliance Global Partners | Buy |
| 2024-07-19 | Fortgesetzt | Canaccord Genuity | Buy |
| 2023-10-09 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-07-19 | Fortgesetzt | Canaccord Genuity | Buy |
Cibus Inc Aktie (CBUS) Neueste Nachrichten
CBUS PE Ratio & Valuation, Is CBUS Overvalued - Intellectia AI
Wall Street Zen Downgrades Cibus (NASDAQ:CBUS) to Sell - MarketBeat
CBUS Q2 2026 Earnings: Wider-Than-Expected Loss as Gene-Editing Platform Awaits Commercial ScaleTax Rate Impact - dars.gov.et
Cibus (NASDAQ:CBUS) Trading 1.3% HigherWhat's Next? - MarketBeat
Cibus (CBUS) Reports Q2 Loss, Misses Revenue Estimates - Eastern Progress
Calibre One Assists Cibus with CEO Search - Hunt Scanlon Media
Cibus (CBUS) Outlook: Closes with Limited Movement at $1.70 in the Latest Session; Chart View - vinanet.vn
EU rules favor Cibus non-transgenic crop improvements - scanx.trade
Cibus (CBUS) Q2 2026 Earnings Call Transcript - AOL.com
Cibus (CBUS) Session: Finishes 1.18% Down at $1.68 in Latest Trading; Immediate View: the $1.60 to $1.76 Range Remains in Focus in the Current UpdateFibonacci Retracement - vinanet.vn
Cibus Inc (CBUS) Stock News Today - TradingKey
HC Wainwright Estimates Cibus' Q3 Earnings (NASDAQ:CBUS) - MarketBeat
Cibus Inc: Interoc Expands Rice Trade to 5 Traits, 36% Revenue Growth – Quarterly Update Report - Yahoo Finance
Cibus Inc: Interoc Expands Rice Trade to 5 Traits, 36% Revenue Growth – Downloadable Quarterly Update Report - Yahoo Finance
HC Wainwright Issues Pessimistic Forecast for Cibus Earnings - MarketBeat
Cibus Is Trying To Turn Gene-Edited Traits Into Royalties - Finimize
Cibus Inc. (CBUS) Drops 6.84% to $1.77, Testing Critical Support at $1.68Breadth Thrust - vinanet.vn
Teleconferência de Resultados do 2T26 da Cibus (CBUS): Lançamento do Arroz Passa para 2028 com Queda de Custos - TradingKey
CBUS Q2 2026 Earnings: Wider Loss and Nil Revenue Reinforce Pre-Commercial ProfileProfit Cycle Analysis - vinanet.vn
Cibus Inc. (CBUS) Edges Higher at $1.90 as Shares Test Technical ResistanceComposite Profile - vinanet.vn
Cibus, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Conferencia de resultados del T2 de 2026 de Cibus (CBUS): El lanzamiento del arroz se traslada a 2028 a medida que disminuyen los costos - TradingKey
Cibus (CBUS) Q2 2026 Earnings Call: Rice Launch Moves to 2028 as Costs Decline - TradingKey
Cibus Inc (CBUS) (Q2 2026) Earnings Call Highlights: Strategic P - GuruFocus
Cibus Q2 2026 Earnings Call Transcript - MarketBeat
CBUS Looks 4.7% Undervalued on GF Value™ - GuruFocus
Cibus (NASDAQ:CBUS) Releases Earnings Results - MarketBeat
Cibus Q2 Earnings Call Highlights - MarketBeat
Earnings call transcript: Cibus Q2 2026 revenue miss sparks 16% after-hours drop - Investing.com
Cibus Q2 Results: Revenue rises 11% YoY, cash usage drops 31% - scanx.trade
Transcript: Cibus Q2 2026 Earnings Conference Call - Benzinga
Cibus Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Cibus: Q2 Earnings Snapshot - marketscreener.com
Cibus (CBUS) cuts costs but warns on going concern amid Q2 2026 loss - Stock Titan
Q2 2026 Cibus Inc Earnings Call Transcript - GuruFocus
Cibus (CBUS) narrows Q2 2026 loss as cash burn falls and regulatory tailwinds build - Stock Titan
Cibus Reports Second Quarter Financial Results and Provides Business Update - The Manila Times
Earnings To Watch: Cibus Inc (CBUS) Q2 2026 -- GF Value Sees 14% Downside - Yahoo Finance
CBUS Q1 2026 Earnings: Modest EPS Beat Signals Cost DisciplineSubscription Growth Report - dars.gov.et
Cibus Inc. (CBUS) Jumps 6.6% to $1.93, Holding Above Key SupportSafe Entry Stocks - dars.gov.et
Cibus to Report Second Quarter 2026 Financial Results on August 13, 2026 After the Market Close and Host Conference Call - 富途牛牛
CBUS Q1 2026 Earnings: Narrower-Than-Expected Loss of -$0.33, Shares Edge Down 3.21%Profit Guidance Range - careplusvn.com
Cibus Inc (CBUS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CBUS Q2'26 Earnings: revenue estimate is 1.70M USD - TradingView
Cibus (CBUS) Projected to Post Quarterly Earnings on Thursday - MarketBeat
CBUS Dips 3.11% to $1.87: Cibus Inc. Tests Key Support at $1.78Thematic ETF Flow - dars.gov.et
Cibus Inc. (CBUS) Advances 1.59% to $1.92: Biotech Stock Holds Key Support Amid ConsolidationAdaptive Moving Average - dars.gov.et
Cibus Inc. (CBUS) Steadies at $1.93: Consolidation Between $1.83 Support and $2.03 ResistanceRetail Driven Moves - dars.gov.et
Cibus to Report Second Quarter 2026 Financial Results on August 13, 2026 After the Market Close ... - Caledonian Record
Cibus to Report Second Quarter 2026 Financial Results on - GlobeNewswire
Cibus Inc. (CBUS) Gains 7.18% as Stock Approaches Key Resistance LevelBuffered ETF - dars.gov.et
Finanzdaten der Cibus Inc-Aktie (CBUS)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.06%
2.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):